Meeting
2021 Gastrointestinal Cancers Symposium
Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.
Authors
Laura Miotke
University of Utah School of Medicine, Salt Lake City, UT
Laura Miotke , Christopher Duane Nevala-Plagemann , Jian Ying , Vaia Florou , Benjamin Haaland , Ignacio Garrido-Laguna
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Pancreatic Cancer
Track
Pancreatic Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 387)
DOI
10.1200/JCO.2021.39.3_suppl.387
Abstract #
387
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.
First Author: Julien Taieb
Poster
2021 Gastrointestinal Cancers Symposium
Population-based, real-world prognostic factors related to survival among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
First Author: Kenneth H. Yu
Poster
2020 ASCO Virtual Scientific Program
A randomized phase II study of second-line treatment with liposomal irinotecan, and S-1 versus liposomal irinotecan and 5-fluorouracil in gemcitabine-refractory metastatic pancreatic cancer patients.
First Author: Esther Pijnappel
Poster
2020 Gastrointestinal Cancers Symposium
Pancreatic adenosquamous carcinoma: Clinical associations, treatment, and outcomes.
First Author: Mindy L. Hartgers